PATENT CLAIM ANALYSIS

Application Number: 16097440
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["514", "340000"]

Abstract:
Compounds of the formula I in which X, Y, R 1  and R 2  have the meanings indicated in claim  1 , are inhibitors of pyruvate dehydrogenase kinase (PDHK), and can be employed, inter alia, for the treatment of diseases such as cancer.

Claim (Index 2):
Compounds according to  claim 1 , in which\n R 3  denotes H or CH 3 , and pharmaceutically acceptable salts, tautomers and stereoisomers thereof, including mixtures thereof in all ratios.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 97.0
- Lexical Diversity: 1.34211
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15105154', '15748786', '14420003', '16069326', '15039226']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7806946681705702
- 35 USC 102 Novelty (BERT): 0.5653429436856667
- Combined Prediction Score: 0.75915949572208
- Mean Citation Score: 359.29564
- Max Citation Score: 434.02216
- Similarity Product: 358.70630214158064

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test